Role of Nucleoside Transporters in Nucleoside-Derived Drug Sensitivity

Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3

(2009) Rajgopal Govindarajan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The H Syndrome Is Caused by Mutations in the Nucleoside Transporter hENT3

(2008) Vered Molho-Pessach et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells

(2008) J. Cai et al.   CANCER RESEARCH

A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum

(2008) Ekaitz Errasti-Murugarren et al.   FASEB JOURNAL

Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells

(2008) Eric I. Zimmerman et al.   FEBS LETTERS

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

(2008) James J. Farrell et al.   GASTROENTEROLOGY

Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells

(2008) M. Lopez-Guerra et al.   HAEMATOLOGICA

Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia

(2008) Roger Y Tsang et al.   MODERN PATHOLOGY

Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells

(2007) Pedro Cano-Soldado et al.   BIOCHEMICAL PHARMACOLOGY